Greatly Health Raises $4M to Expand Access to Evidence-Based Integrative Cancer Care
The company is building the clinical intelligence and intervention layer to deliver whole-person cancer care at scale. NEW YORK CITY,...
The company is building the clinical intelligence and intervention layer to deliver whole-person cancer care at scale. NEW YORK CITY,...
Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical Center. MIAMI,...
Some of Kraig Labs recently Reeled recombinant Spider Silk Some of Kraig Labs recently Reeled recombinant Spider Silk DENVER, April...
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad...
Appointment signals next phase of expansion for HIFU-based prostate care as demand grows for non-invasive, function-preserving treatment optionsCHARLOTTE, N.C., April...
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)...
Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distributionAdds Filament's extensive intellectual property portfolio, including...
Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the...
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company...
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company...
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company...
Grants support discovery and development of novel drug candidates and evaluation and prioritization of advanced drug regimens for clinical testingNew...
An Evidence-Based Supplement Formulated to Improve Testosterone Levels* ROCKVILLE, MD / ACCESS Newswire / April 30, 2026 / Theralogix, a...
"Without clinical evidence, without public notice, and without congressional authorization, the federal government inserted psychoactive consumer products into Medicare -...
The January 2025 Transaction Leverages Advanced Administrative Restructuring to Secure a Strategic Exit for the Founding Physician and Establish a...
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company"...
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"),...
Collaboration to automate documentation, coding, and EMR workflows-reducing clinician burden, improving revenue performance, and enhancing patient care across community oncology...
MESA, AZ / ACCESS Newswire / April 29, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced a...
Doheny scientists, clinician-scientists, and research fellows will present findings on eye disease, advanced imaging, artificial intelligence and more at the...